References
- Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–700.
- Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–41.
- Mulder DW, Howard RM. Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc. 1976;51: 537–41.
- Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
- Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008;70:144–52.
- Linnebank M, Lutz H, Jarre E, Vielhaber S, Noelker C, Struys E, . Binding of copper is a mechanism of homocysteine toxicity leading to Cox deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells. Neurobiol Dis. 2006;23:725–30.
- Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, . Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother. 2009;9: 1393–412.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. A Consensus Conference held at Airlie House, Warrenton, Virginia April 2–4, 1998. World Federation of Neurology Research Group on Motor Neuron Disease.
- Linnebank M, Moskau S, Jürgens A, Simon M, Semmler A, Orlopp K, . Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro Oncol. 2009;11:2–8.
- Linnebank M, Homberger A, Nowak-Göttl U, Marquardt T, Harms E, Koch HG. Linkage disequilibrium of the common mutations 677C>T and 1298A>C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C>T, 1068C>T. Eur J Pediatr. 2000; 159:472–3.
- van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, . Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070–1.
- Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, . Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev Neurother. 2009;9: 1393–412.
- Linnebank M, Montenarh M, Kölsch H, Linnebank A, Schnez K, Schweichel D, . Common genetic variants of homocysteine metabolism in ischaemic stroke: a case-control study. Eur J Neurol. 2005;12:614–8.
- Linnebank M, Moskau S, Farmand S, Fliessbach K, Kölsch H, Bös M, . Homocysteine and carotid intima-media thickness in a German population: lack of clinical relevance. Stroke. 2006;37:2840–2.
- Linnebank M, Semmler A, Moskau S, Smulders Y, Blom H, Simon M. The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro Oncol. 2008;10:548–52.